文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

比较城乡环境下多囊卵巢综合征的代谢组学特征。

Comparing the metabolomic landscape of polycystic ovary syndrome within urban and rural environments.

作者信息

Patel Jalpa, Chaudhary Hiral, Chudasama Abhishek, Panchal Jaydeep, Trivedi Akanksha, Panchal Sonal, Joshi Trupti, Joshi Rushikesh

机构信息

Department of Biochemistry and Forensic Science, University School of Sciences, Gujarat University, Ahmedabad, Gujarat, India.

Advait Theragnostics Pvt Ltd, Ahmedabad, Gujarat, India.

出版信息

Commun Med (Lond). 2025 Jul 1;5(1):253. doi: 10.1038/s43856-025-00985-6.


DOI:10.1038/s43856-025-00985-6
PMID:40593337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12214864/
Abstract

BACKGROUND: Polycystic Ovary Syndrome (PCOS) affects up to 10% of women of reproductive age, characterized by hormonal imbalances and metabolic complications. Environmental factors potentially influence the biochemical expression of this condition. This study aims to examine the impact of urban versus rural environments on metabolite profiles in women with PCOS. METHODS: Thirty women aged between 18 and 40, diagnosed with PCOS according to the Rotterdam 2003 criteria, were recruited from June 2022 to May 2023, 16 from urban settings and 14 from rural settings. Serum samples were analyzed using liquid chromatography-tandem mass spectrometry. Principal component analysis and orthogonal partial least squares discriminant analysis were performed to identify metabolic patterns and differences between the two groups. RESULTS: This study reveals significant differences in metabolite profiles between women with PCOS from various environmental backgrounds. Rural participants exhibit higher levels of lipid-related metabolites, especially Palmitone, indicating specific dietary influences. Urban participants show distinct changes in carbohydrate and nucleotide metabolism pathways, likely due to processed food consumption. Multivariate analyses demonstrate a clear separation between the groups, emphasizing the environmental impact on PCOS expression. CONCLUSIONS: This research highlights potential environment-related biomarkers for PCOS, emphasizing the importance of developing tailored treatment strategies considering environmental factors. The distinct metabolic profiles observed between urban and rural women provide new insights into the syndrome's complex mechanisms, indicating that environmental influences play a critical role in its biochemical expression and may affect its clinical manifestations.

摘要

背景:多囊卵巢综合征(PCOS)影响着高达10%的育龄女性,其特征为激素失衡和代谢并发症。环境因素可能会影响这种病症的生化表现。本研究旨在探讨城市环境与农村环境对PCOS女性代谢物谱的影响。 方法:2022年6月至2023年5月招募了30名年龄在18至40岁之间、根据2003年鹿特丹标准诊断为PCOS的女性,其中16名来自城市地区,14名来自农村地区。使用液相色谱-串联质谱法分析血清样本。进行主成分分析和正交偏最小二乘法判别分析,以识别两组之间的代谢模式和差异。 结果:本研究揭示了来自不同环境背景的PCOS女性在代谢物谱方面存在显著差异。农村参与者的脂质相关代谢物水平较高,尤其是棕榈酮,表明存在特定的饮食影响。城市参与者在碳水化合物和核苷酸代谢途径中表现出明显变化,可能是由于加工食品的消费。多变量分析表明两组之间有明显区分,强调了环境对PCOS表现的影响。 结论:本研究突出了PCOS潜在的与环境相关的生物标志物,强调了考虑环境因素制定个性化治疗策略的重要性。城市和农村女性之间观察到的不同代谢谱为该综合征的复杂机制提供了新的见解,表明环境影响在其生化表现中起关键作用,并可能影响其临床表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/16aa85270d1b/43856_2025_985_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/48a05c0c6c01/43856_2025_985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/d0b6cfd8af60/43856_2025_985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/979e073071f5/43856_2025_985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/6d16408ecc8c/43856_2025_985_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/a528ef089c03/43856_2025_985_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/f8802c5c8130/43856_2025_985_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/16aa85270d1b/43856_2025_985_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/48a05c0c6c01/43856_2025_985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/d0b6cfd8af60/43856_2025_985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/979e073071f5/43856_2025_985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/6d16408ecc8c/43856_2025_985_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/a528ef089c03/43856_2025_985_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/f8802c5c8130/43856_2025_985_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262a/12214864/16aa85270d1b/43856_2025_985_Fig7_HTML.jpg

相似文献

[1]
Comparing the metabolomic landscape of polycystic ovary syndrome within urban and rural environments.

Commun Med (Lond). 2025-7-1

[2]
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.

Int J Gynaecol Obstet. 2025-6-25

[3]
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.

Hum Reprod. 2017-5-1

[4]
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.

Cochrane Database Syst Rev. 2017-11-10

[5]
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Cochrane Database Syst Rev. 2017-11-29

[6]
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.

Eur J Obstet Gynecol Reprod Biol. 2022-4

[7]
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.

Cochrane Database Syst Rev. 2022-9-27

[8]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[9]
Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles.

Front Endocrinol (Lausanne). 2025-6-3

[10]
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.

Cochrane Database Syst Rev. 2021-10-27

本文引用的文献

[1]
Connecting Bisphenol A Exposure to PCOS: Findings from a Case-Control Investigation.

Reprod Sci. 2024-8

[2]
Endocrine-disrupting chemicals and hormonal profiles in PCOS women: A comparative study between urban and rural environment.

Reprod Toxicol. 2024-4

[3]
Androgen excess: a hallmark of polycystic ovary syndrome.

Front Endocrinol (Lausanne). 2023

[4]
Association of FTO gene variant rs9939609 with polycystic ovary syndrome from Gujarat, India.

BMC Med Genomics. 2023-9-14

[5]
Assessment of gut microbial β-glucuronidase and β-glucosidase activity in women with polycystic ovary syndrome.

Sci Rep. 2023-7-24

[6]
Environmental Pollution and the Risk of Developing Metabolic Disorders: Obesity and Diabetes.

Int J Mol Sci. 2023-5-17

[7]
OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome.

Reproduction. 2022-12-1

[8]
Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study.

Int J Reprod Biomed. 2022-4-21

[9]
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.

Int J Mol Sci. 2022-1-6

[10]
Weight gain and lifestyle factors in women with and without polycystic ovary syndrome.

Hum Reprod. 2021-12-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索